美國2025年度生技醫藥產業趨勢分析報告
https://geneonline.news/2025-us-biopharma-outlook/

2024年十大基因與細胞療法:重大突破、獲准產品、臨床試驗、投融資概況、政策法規變化
https://geneonline.news/top-10-gene-and-cell-therapy-2024/

亞洲2025年度生技醫藥趨勢分析報告
https://geneonline.news/2025-asia-biopharma-outlook/

專利到期之際、繼往開來之時:2025至2030年藥物專利懸崖全面解析
https://geneonline.news/2025-2030-drug-patent-cliff-research/

台灣浩鼎受邀倫敦世界ADC大會，首度公開連接子技術關鍵
https://geneonline.news/taiwans-obi-pharma-invited-london-world-adc-conference-unveils-key-linker-technology-for-the-first-time/

克服RNA技術痛點!國衛院研發新式環狀RNA合成法
https://news.gbimonthly.com/tw/article/show.php?num=74839

抗憂鬱藥物可能加速認知退化:療效與風險的兩難
https://geneonline.news/ssris-may-relate-to-cognitive-decline/

轉移性前列腺癌治療新趨勢:晚期確診率高,死亡率十年暴增44%
https://geneonline.news/new-trends-in-metastatic-prostate-cancer-treatment-high-rate-of-late-stage-diagnosis-mortality-surges-44-over-a-decade/#prettyPhoto

大型語言模型:合成生物學與AI強化生技製造的未來
https://geneonline.news/%e5%a4%a7%e5%9e%8b%e8%aa%9e%e8%a8%80%e6%a8%a1%e5%9e%8b%ef%bc%9a%e5%90%88%e6%88%90%e7%94%9f%e7%89%a9%e5%ad%b8%e8%88%87ai%e5%bc%b7%e5%8c%96%e7%94%9f%e6%8a%80%e8%a3%bd%e9%80%a0%e7%9a%84%e6%9c%aa%e4%be%86/

AI將提升藥廠多元與包容性,加速臨床試驗
https://geneonline.news/ai%e5%b0%87%e6%8f%90%e5%8d%87%e8%97%a5%e5%bb%a0%e5%a4%9a%e5%85%83%e8%88%87%e5%8c%85%e5%ae%b9%e6%80%a7%ef%bc%8c%e5%8a%a0%e9%80%9f%e8%87%a8%e5%ba%8a%e8%a9%a6%e9%a9%97/

《Science》AI模型Evo問世，從基因序列推演全新蛋白質
https://news.gbimonthly.com/tw/article/show.php?num=72703

有史以來最大生物學AI模型Evo-2!首創預測非編碼突變
https://news.gbimonthly.com/tw/article/show.php?num=74613

當量子運算遇上生物學:讓我們談談現代跨領域學科的榮景
https://geneonline.news/the-connection-between-quantum-biology-and-the-tech-industry-pioneering-a-new-era-in-science-and-medicine/

美國關稅政策,對台生技醫藥業影響分析
https://geneonline.news/impact-of-us-tariff-policy-on-taiwan-biopharma/

受美國對等關稅影響最大的幾個台灣生技業廠商
https://geneonline.news/%e5%8f%97%e7%be%8e%e5%9c%8b-%e5%b0%8d%e7%ad%89%e9%97%9c%e7%a8%85-%e5%bd%b1%e9%9f%bf%e6%9c%80%e5%a4%a7%e7%9a%84%e5%b9%be%e5%80%8b%e5%8f%b0%e7%81%a3%e7%94%9f%e6%8a%80%e6%a5%ad%e5%bb%a0%e5%95%86/

2025年FDA審核在即:盤點十大首創新藥
https://geneonline.news/2025-fda-first-in-class-drugs-are-on-the-approval-waiting-line/

Colossal基因編輯「復活」恐狼,真實上演《侏羅紀世界》
https://geneonline.news/colossal-biosciences-dire-wolf-de-extinction/

《Science》張鋒推創新TIGR基因編輯系統比Cas9更小、更靈活
https://news.gbimonthly.com/tw/article/show.php?num=75876

新型生物標記,為AD血液檢測帶來突破
https://geneonline.news/plasma-mtbr-tau243-biomarker-identifies-tau-tangle-pathology-in-alzheimers-disease/

捐血一袋,不只救人一命:捐血竟會改變基因?
https://geneonline.news/clonal-hematopoiesis-landscape-in-frequent-blood-donors/

不需iPSC轉化!?MIT科學家直接將皮膚細胞分化為神經元
https://news.gbimonthly.com/tw/article/show.php?num=75514&utm_source=dable

日本外泌體產官學界第一線挑戰與契機
https://geneonline.news/challenges-and-regulations-of-extracellular-vesicles-in-clinical-development/

醫療AI全球競局啟動:陳良基全盤解析市場潛力、挑戰與台灣機會
https://geneonline.news/chen-liang-gee-on-medical-ai/

醫療創新不保證市場成功:了解真正市場需求,打動五大利害關係人
https://geneonline.news/innovation-alone-doesnt-guarantee-market-success-darren-cooke/